The Texas Board of Pharmacy on Wednesday finally passed its updated rules for compounding. If you li...
Even pharmacists can lose an initialism or acronym or two in a metaphorical bowl of alphabet soup. T...
Sara Talpos’s article about peptides in Undark (and also published in Stat News) might be the most t...
There’s good news on the drug-shortages front, according to the latest report from the American Soci...
HHS’s Office of the Inspector General has issued a new advisory bulletin about pharma manufacturers ...
With patents for semaglutide expiring in the not-too-distant future, Novo Nordisk is pulling out all...
According to a ProPublica analysis, “the FDA has lost more than 400 workers who support inspections ...
Number 6 will blow your mind! We just love* the clickbait headline from Everyday Health: “9 Signs Yo...
Running for the board? If you’re thinking about running for the 2025–26 APC Board of Directors, don’...
This week in Compounding Interests. Scott talks about the shortage of bright-line compliance standar...